Investigate FDA for withholding Melanoma treatment, disrespecting trial patients

To: Pres. Trump, Sen. Kelly, Rep. Schweikert, Sen. Gallego

From: A verified voter in Scottsdale, AZ

July 24

Please investigate the FDA for issuing the CLR but withholding approval for a new melanoma treatment. They didn’t withhold because it was unsafe or ineffective just that they didn’t like the trial design pre-approved by the FDA. This is disrespectful to the patients who volunteered for this study. They trusted their doctors and the FDA that their participation could help others. Many of these trial participants are from Arizona (HonorHealth). You have a duty to call for accountability for the FDA overstepping their bounds and harming patients. FDA Issues CRL for RP1 Plus Nivolumab for Advanced Melanoma

Write to Donald Trump or any of your elected officials

Send your own letter

Or text write to 50409

Resistbot is a chatbot that delivers your texts to your elected officials by email, fax, or postal mail. Tap above to give it a try or learn more here!